Molecular imaging in clinical trials accelerates the development of promising compounds by allowing physicians to see ...
Contrast Media
Contrast media, also called contrast agents, are used to enhance the blood and perfusion in tissues. This includes iodine based contrast for on computed tomography (CT), gadolinium based agents for MRI and lipid bubble contrast agents used in ultrasound.
June 2, 2009 - Celsense Inc. reported it is one of the recipients in a four-year $1.95 million grant from the National ...
May 28, 2009 - Lantheus Medical Imaging Inc. has completed patient enrollment of CaRES (Contrast Echocardiography ...
Bayer Radiology’s Barbara Ruhland and Thom Kinst discuss how radiology departments can address the many different ...
May 20, 2009 – Lantheus Medical Imaging Inc. has signed an agreement with NTP Radioisotopes (Pty) Ltd., a subsidiary of ...
May 8, 2009 – Siemens Healthcare has filed an exploratory Investigational New Drug (eIND) application with the FDA for a ...
The MEDRAD Informatics Solution platform uses a service-oriented architecture that automates capture of power injection ...
Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...
March 31, 2009 – Lantheus Medical Imaging Inc. reported that its novel fluorine 18-labeled positron emission tomography ...
March 30, 2009 – Lantheus Medical Imaging Inc. released at ACC 2009 new data regarding the use of DEFINITY Vial For ...
March 25, 2009 – Lantheus Medical Imaging Inc. today announced that new data for the company’s echocardiography contrast ...
A patient’s chance of recovery can be directly impacted when a diagnosis is missed or delayed. To get the right ...
February 24, 2009 - Lantheus Medical Imaging Inc. today said a paper published online in the February 2009 issue of the ...
February 18, 2009 - MEDRAD’s Intego PET Infusion System has been named one of Medical Imaging Magazine’s top eight most ...
January 26, 2009 - FluoroPharma Inc., a company developing bolecular imaging agents for the Positron Emission Tomography ...
Product Indications and Use: CLARISCAN (gadoterate meglumine) is a gadolinium-based contrast agent indicated for ...
January 20, 2009 - Cambridge Research & Instrumentation (CRi) and VisEn Medical signed a non-exclusive agreement to ...
January 8, 2009 – Bayer Schering Pharma AG and Hamamatsu Photonics K.K., Japan have signed a licensing agreement for the ...
January 6, 2009 - MEDRAD has agreed to collaborate with the University of Zurich in a study on dynamic PET imaging with ...
January 5, 2009 - Arlington Medical Resources (AMR), a provider of market intelligence for the pharmaceutical and ...
December 31, 2008 – According to results from a Phase 2 clinical study (BP-23), Zemiva, when combined with the standard ...
December 31, 2008 - The FDA today approved Vasovist Injection (gadofosveset trisodium), manufactured by EPIX ...
December 29, 2008 – When Zemiva, an imaging agent by Molecular Insight Pharmaceuticals Inc., is combined with the ...
December 23, 2008 – The FDA approved for marketing EPIX Pharmaceuticals’ novel blood pool magnetic resonance angiography ...
June 10, 2009 